RestorixHealth is a leading manager of comprehensive wound care treatment centers that offer advanced wound care modalities as well as hyperbaric oxygen therapy (“HBOt”). The Company manages wound care centers nationwide in partnership with local acute care hospitals. RestorixHealth was founded by physicians in 1997 with a focus on establishing in-hospital centers of excellence to treat the growing incidence of severe grade diabetic wounds of the lower extremities and wounds that are unresponsive to general wound care treatments. The Company’s centers have consistently achieved high treatment success rates, resulting in a dramatic increase in patient quality of life and significant cost savings to the healthcare system. Restorix was sold in 2015 to Leonard Green & Partners.
“Sverica was instrumental in propelling RestorixHealth from a regional player to a national footprint. Their expertise in financing and M&A were keys that allowed the company to grow in both a de novo as well as acquisitive manner. During Sverica’s investment period, the company completed three acquisitions that added management depth, clinical expertise, and provided necessary scale to position RestorixHealth as an industry leader.”